[Immunomodulation treatment of inflammatory bowel disease].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000917:Antibody Formation / Q000187:drug effects; D001379:Azathioprine / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D003424:Crohn Disease / Q000188:drug therapy*; D004338:Drug Combinations / Q000627:therapeutic use; D005944:Glucosamine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012460:Sulfasalazine / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; C028423:Salazopyrine; D012460:Sulfasalazine; D011239:Prednisolone; D001379:Azathioprine; D005944:Glucosamine; D011241:Prednisone
Immunmodulerende behandling ved inflammatoriske tarmsykdommer.